Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Validity and Reliability of a Commercially-Available Velocity and Power Testing Device.

Askow AT, Stone JD, Arndts DJ, King AC, Goto S, Hannon JP, Garrison JC, Bothwell JM, Esposito PE, Jagim AR, Jones MT, Jennings W, Oliver JM.

Sports (Basel). 2018 Dec 10;6(4). pii: E170. doi: 10.3390/sports6040170.

2.

Omega-conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neurons.

Lalo UV, Pankratov YV, Arndts D, Krishtal OA.

Brain Res Bull. 2001 Mar 15;54(5):507-12.

PMID:
11397540
3.

New channel blocker BIIA388CL blocks delayed rectifier, but not A-type potassium current in central neurons.

Krishtal O, Kirichok Y, Tsintsadze T, Lozovaya N, Loesel W, Arndts D.

Neuropharmacology. 2001;40(2):233-41.

PMID:
11114402
4.

Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.

Tatlisumak T, Carano RA, Takano K, Meiler MR, Li F, Sotak CH, Arndts D, Pschorn U, Fisher M.

J Neurol Sci. 2000 Sep 15;178(2):107-13.

PMID:
11018702
5.

LOE 908 blocks delayed rectifier type potassium channels in PC12 cells and cortical neurons in culture.

Krause E, Pfeiffer F, Schmid A, Arndts D, Schulz I.

Biochem Biophys Res Commun. 1998 Mar 27;244(3):659-64.

PMID:
9535721
6.

Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.

Krautwurst D, Hescheler J, Arndts D, Lösel W, Hammer R, Schultz G.

Mol Pharmacol. 1993 May;43(5):655-9.

PMID:
7684814
7.

[Drug research and insurance medicine].

Arndts D, Wollnitz G.

Versicherungsmedizin. 1990 Feb 1;42(1):28-31. German.

PMID:
2316102
8.

Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.

Arndts D, Arndts K.

Eur J Clin Pharmacol. 1984;26(1):79-85.

PMID:
6714294
9.
10.

New aspects of the clinical pharmacology of clonidine.

Arndts D.

Chest. 1983 Feb;83(2 Suppl):397-400.

PMID:
6822136
11.

New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.

Arndts D, Doevendans J, Kirsten R, Heintz B.

Eur J Clin Pharmacol. 1983;24(1):21-30.

PMID:
6832197
12.

Alinidine pharmacokinetics following acute and chronic dosing.

Harron DW, Arndts D, Shanks RG.

Br J Clin Pharmacol. 1982 Jun;13(6):821-7.

13.

Development of a RIA for clonidine and its comparison with the reference methods.

Arndts D, Stähle H, Förster HJ.

J Pharmacol Methods. 1981 Dec;6(4):295-307.

PMID:
7334811
14.

Development and quality control of a highly sensitive radioimmunoassay for alinidine.

Arndts D, Stähle H.

J Pharmacol Methods. 1981 Sep;6(2):109-20.

PMID:
7289628
15.

New aspects in the metabolism of alinidine in man.

Arndts D, Forster HJ.

Eur J Drug Metab Pharmacokinet. 1981;6(4):313-5. No abstract available.

PMID:
7333332
16.

Proof of the linearity of the pharmacokinetics of alinidine in man.

Arndts D, Warnkross H, Rominger KL, Justus H.

Eur J Clin Pharmacol. 1981;21(3):201-7.

PMID:
7318879
17.

Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.

Arndts D, Leb G, Förster HJ.

Eur J Drug Metab Pharmacokinet. 1981;6(3):225-36.

PMID:
7308242
19.

A newly developed precise and sensitive radioimmunoassay for clonidine.

Arndts D, Stähle H, Struck CJ.

Arzneimittelforschung. 1979;29(3):532-8.

PMID:
582739
20.

[Metabolite isolation for mass spectrometrical determination of new drugs (author's transl)].

Arndts D, Rominger KL.

Arzneimittelforschung. 1978;28(11a):1951-60. German.

PMID:
582524
21.

Experimental investigation of possible cardiotoxic effects on the offspring of rats treated with high doses of fenoterol.

Notman J, Rominger KL, Niggeschulze A, Arndts D.

J Perinat Med. 1977;5(5):206-13. No abstract available.

PMID:
592081
22.

Mass spectral analysis of glucuronides from sympathomimetic hydroxyphenylalkylaminoethanols.

Pook KH, Rominger KL, Arndts D.

J Pharm Sci. 1976 Oct;65(10):1513-8.

PMID:
978413
23.

Drug effects on myocardial 45Ca uptake in conscious rats.

Arndts D.

Arzneimittelforschung. 1975 Aug;25(8):1279-84.

PMID:
241363
24.

A solid phase radioimmunoassay for digoxin and its acylated derivatives.

Arndts D.

Naunyn Schmiedebergs Arch Pharmacol. 1975;287(3):309-19.

PMID:
1153022
25.

Proceedings: A simple screening method for the evaluation of beta-sympatholytics.

Arndts D, Traunecker W, O'svath J.

Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R2. No abstract available.

PMID:
4152356
26.

[Behavior of Trasylol in the body as a model for the pharmacokinetics of basic polypeptides].

Habermann E, Arndts D, Just M, Räker KO, Török P.

Med Welt. 1973 Jul 27;24(29):1163-7. German. No abstract available.

PMID:
4542586
27.

The pharmacokinetics and metabolism of Kö592 in man, dog and rat.

Arndts D, Pollmann W.

Naunyn Schmiedebergs Arch Pharmacol. 1973;277(4):349-62. No abstract available.

PMID:
4145200
28.

[Studies on the distribution and elimination of a proteinase inhibitor with isotope technics].

Arndts D, Räker KO, Török P, Habermann E.

Arzneimittelforschung. 1970 May;20(5):667-74. German. No abstract available.

PMID:
5310538
29.

[Radio-retention electropnoresis: a quantitative and specific method for the determination of single proteins in the nanogram field].

Habermann E, Räker KO, Arndts D.

Klin Wochenschr. 1968 Jan 1;46(1):46-7. German. No abstract available.

PMID:
5691488

Supplemental Content

Loading ...
Support Center